Education
About Us
Working with TipRanks
Follow Us
BioRegenx (BRGX)
OTHER OTC:BRGX
BRGX Stock Chart & Stats
$0.01
>-$0.01(-6.33%)
At close: 4:00 PM EST
$0.01
>-$0.01(-6.33%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.03
Previous CloseN/A
Volume1.00K
Average Volume (3M)59.55K
Market Cap
$10.00M
Enterprise Value$12.20M
Total Cash (Recent Filing)$46.95K
Total Debt (Recent Filing)$2.25M
Price to Earnings (P/E)―
Beta0.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding961,992,600
10 Day Avg. Volume11,689
30 Day Avg. Volume59,554
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.50
Price to Sales (P/S)3.61
P/FCF Ratio-16.47
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue6.33
Enterprise Value/Gross Profit3.96
Enterprise Value/Ebitda-0.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BRGX FAQ
What was BioRegenx’s price range in the past 12 months?
BioRegenx lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is BioRegenx’s market cap?
BioRegenx’s market cap is $10.00M.
When is BioRegenx’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioRegenx’s earnings last quarter?
Currently, no data Available
Is BioRegenx overvalued?
According to Wall Street analysts BioRegenx’s price is currently Overvalued.
Does BioRegenx pay dividends?
BioRegenx does not currently pay dividends.
What is BioRegenx’s EPS estimate?
BioRegenx’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioRegenx have?
BioRegenx has 961,992,600 shares outstanding.
What happened to BioRegenx’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioRegenx?
Currently, no hedge funds are holding shares in BRGX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BioRegenx
BioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally. The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products. It also develops TruScan.Ai mobile app/website that integrates additional health indicators; and VitalWellness app, which merge its DNA and epigenetics platform. In addition, the company operates a social media content management platform, including its interactive search engine. Further, it provides DocSun Artificial Intelligence (AI) Engine, which integrates advanced ballistocardiography that detects an individual's heartbeat without touch; photoplethysmography, a method that uses light to track the flow of blood; and distributes wellness devices. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.
Technical Analysis
Matinas BioPharma
―
IN8bio
―
HCW Biologics
―
Calidi Biotherapeutics
―
Mainz Biomed B.V.
―